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ABSTRACT 
Background: Chronic obstructive pulmonary disease (COPD) is characterized by 
airflow limitation caused by emphysema and small airway narrowing.  Quantitative 
evaluation of airway dimensions by multi-detector computed tomography (MDCT) has 
revealed a correlation between airway dimension and airflow limitation.  However, the 
effect of emphysema on this correlation is unclear.  
 
Objective: The goal of this study was to determine whether emphysematous changes 
alter the relationships between airflow limitation and airway dimensions as measured by 
inspiratory and expiratory MDCT. 
 
Methods: Ninety-one subjects underwent inspiratory and expiratory MDCT. Images 
were evaluated for mean airway luminal area (Ai), wall area percentage (WA%) from 
the third to the fifth generation of three bronchi (B1, B5, B8) in the right lung, and low 
attenuation volume percent (LAV%).  Correlations between each airway index and 
airflow limitation were determined for each patient and compared between patients with 
and without evidence of emphysema.  
 
Results: In patients without emphysema, Ai and WA% from both the inspiratory and 
expiratory scans were significantly correlated with FEV1. No correlation was detected in 
patients with emphysema.  In addition, emphysematous COPD patients with GOLD 
stage 1 or 2 disease had significantly lower changes in B8 Ai than non-emphysematous 
patients. 
 
Conclusions: A significant correlation exists between airway parameters and FEV1 in 
patients without emphysema. Emphysema may influence airway dimensions even in 
patients with mild to moderate COPD. 
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INTRODUCTION 
   Chronic obstructive pulmonary disease (COPD) is characterized by irreversible 
airflow limitations[1].  Airflow limitation in COPD is caused by airway narrowing and 
loss of lung elastic recoil due to parenchymal and small airway destruction[2, 3]. The 
extent of emphysematous changes can vary widely, even among subjects with the same 
COPD stage[4]. Hence, the presence of emphysema is now considered a key factor in 
determining COPD therapeutic strategies[5, 6]. 
 
   Recent technological advances in multi-detector computed tomography (MDCT) 
have made it possible to more precisely evaluate lung architecture. Densitometry 
parameters including low attenuation area (LAA) and low attenuation volume (LAV) 
have been shown to correlate with airflow limitation in patients with COPD[7-9].  
Previous studies have established the low attenuation volume percentage (LAV%) as an 
accurate index of emphysematous change[9-12]. The quantitative evaluation of airway 
dimensions is more challenging.  Nakano et al.[13] found that the airway dimensions 
of the upper lobe segmental bronchus, as measured by HRCT, correlate with the degree 
of airway obstruction.  Hasegawa et al.[14] reported that airflow limitation in COPD is 
closely related to the wall area percentage (WA%) from the third to the sixth generation 
bronchi.  Finally, Matsuoka et al.[15] reported that airway dimensions calculated from 
expiratory images correlate more closely with airflow limitation than those calculated 
from inspiratory images. 
 
   Pathology studies have shown that loss of alveolar wall attachments due to 
emphysematous destruction leads to bronchiolar deformity and airway narrowing[16], 
resulting in the loss of bronchial dilatory effects[17].  It has thus been postulated that 
emphysema may modify the changes in airway dimensions that occur between  
respiratory phases.  Recently, Diaz et al.[12] reported that emphysema attenuates the 
relationship between forced expiratory volume in 1 second (FEV1) and the WA% of 
subsegmental bronchi as measured by CT.  Additionally, they demonstrated that 
airway distensibility is compromised in emphysematous patients with Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) stage 2 disease compared to those with 
an airway dominant phenotype[18]. However, the effects of emphysema on changes 
between inspiration and expiration in the peripheral airways have yet to be clarified. 
 
   The purpose of this study was to determine whether emphysema influences the 
relationship between peripheral airway dimensions and obstructive impairment and 
whether it alters changes in airway dimensions during inspiration and expiration (Fig. 
1).  
 
MATERIALS and METHODS 
Subjects 
   Ninety-one subjects with diagnosed or suspected COPD were enrolled at Chiba 
University Hospital between February 2009 and October 2012.  All subjects had a 
history of smoking.  The diagnosis of COPD was based on the GOLD criteria[1].  
Patients with heart failure, lung cancer or active lung disease other than COPD were 
excluded from the study. 
The study was approved by the ethics committee of Chiba University School of 
Medicine and all patients gave written informed consent. 
 
MDCT imaging 
 Images were generated on a 64-MDCT (Aquilion-ONE; Toshiba Medical, Tokyo, 
Japan). After careful patient instruction, MDCT images were obtained during a breath 
hold after deep inspiration and again after deep expiration while the patient lay in the 
supine position. CT parameters were as follows: collimation 120 kV; 200 mA 
(CT-AEC); gantry rotation time, 0.5 second; beam pitch, 0.83.  All images were 
reconstructed using a standard reconstruction algorithm with a slice thickness of 0.5 mm 
and a reconstruction interval of 0.5 mm. 
 
CT measurements of airway luminal area, wall area and low attenuation volume 
Image data was transferred to a Ziostation 2（Ziosoft, Tokyo, Japan）[15, 19].  A 
three-dimensional bronchial skeleton was automatically reconstructed from the 
transverse, sagittal, and coronal images. The bronchial pathway was converted to a 
curved multi-plane reconstruction of the bronchial long-axis, from which the bronchial 
short-axis image, which is perpendicular to the long axis, was obtained. The short-axis 
image was used to automatically calculate Ai and WA using the full width at half 
maximum principle[20, 21].  WA% was calculated as 100 × WA / (WA + Ai). The 
outline of the airway wall was manually corrected when the computer-generated outline 
was obviously out of contour. Third (segmental), 4th (subsegmental), and 5th 
(sub-subsegmental) bronchial generations were identified, and mean Ai and WA% 
values were obtained for each generation. Three right bronchi were evaluated: the apical 
bronchus of the upper lobe (B1), the medial bronchus of the middle lobe (B5), and the 
anterior basal bronchus of the lower lobe (B8).  The same bronchus was evaluated on 
the inspiratory and expiratory images. The change in Ai between inspiration and 
expiration was calculated as 100 × (inspiratory Ai – expiratory Ai) / inspiratory Ai.  
Total lung volume (TLV) and LAV, based on a threshold of -960 HU, were also obtained 
[22].  LAV% was calculated as 100 × LAV / TLV. Values were confirmed by a single 
observer (M.Y.) who was blinded to all clinical information. 
 
Pulmonary function tests 
   Pulmonary function tests were performed on a Fudac-60 (Fukuda Denshi, Tokyo, 
Japan) according to American Thoracic Society guidelines.  Vital capacity (VC), 
forced vital capacity (FVC) and FEV1 were measured using standard techniques[23].  
FEV1 and FVC were calculated as a percentage of predicted values.  The ratio of FEV1 
to FVC (FEV1 / FVC) was also expressed as a percentage. 
 
Statistical analysis 
   All statistical analyses were performed with JMP 10.0 software (SAS institute Inc., 
Cary, NC, USA).  Results are expressed as mean ± SD.  Wilcoxon singed-rank test 
was used to compare airway parameters between inspiratory and expiratory images.  
Spearman rank test was used to evaluate the relationship between the airway parameters 
and the results of pulmonary function tests.  Analysis of variance (ANOVA) with 
Turkey-Kramer test was used to compare subgroups.  A p value less than 0.05 was 
considered significant. 
 
 
RESULTS 
Patient characteristics 
   One hundred twenty-four subjects were enrolled in the study. Airway data were 
obtained from both inspiratory and expiratory CT images in 91 patients. Full airway 
data could not be obtained from the remaining 33 patients for the following reasons: 
airway dimensions were too small to measure on expiratory CT images (n = 17);  
airway dimensions were too small to measure on both inspiratory and expiratory CT 
images (n = 12); breathing motion artifacts rendered CT images non-diagnostic (n = 4). 
 
   Patient characteristics, pulmonary function tests and inspiratory LAV% are 
summarized in Table 1.  The number of subjects with COPD in each GOLD stage was 
as follows: stage 1, n = 18 (19.8%); stage 2, n = 33 (36.3%); stage 3, n = 19 (20.9%); 
stage 4, n = 7 (7.7%).  Fourteen (15.4%) smokers with normal pulmonary function 
tests (FEV1 / FVC ≥ 0.7) were also included in the study.  Emphysema was defined as 
LAV% ≥ 5%. The number of smokers with and without emphysema was 27 (29.7%) 
and 64 (70.3%), respectively. 
 
Measurement of CT parameters 
   CT evaluation of Ai and WA% is shown in Table 2.   Mean inspiratory and 
expiratory Ai of the 3rd to 5th generation bronchi ranged from 6.3 ± 2.1 to 17.4 ± 4.5 
mm
2
 and 4.0 ± 1.7 to 13.3 ± 3.6 mm
2
.  The Mean inspiratory and expiratory WA% of 
the 3rd to 5th generation bronchi ranged from 71.0 ± 3.6 to 78.2 ± 3.6 % and 75.0 ± 3.5 
to 83.6 ± 3.7 %.  For all bronchi generations, Ai was significantly larger on inspiratory 
CT images than on expiratory images and WA% was significantly smaller on inspiratory 
CT images than on expiratory images. 
 
   The relationship between FEV1 and each airway dimensions is shown in Table 3.  A 
significant positive correlation was observed between the mean Ai of 4th and 5th 
generation bronchi and FEV1. On both images, a significant negative correlation was 
observed between FEV1 and the mean WA% of all bronchial generations.  The 
correlation coefficients of both Ai and WA% tended to be better on inspiratory images 
than on expiratory images.  In addition, the correlation coefficients of Ai and WA% 
were higher in the peripheral airways. 
 
 The relationships between airway dimensions and obstructive impairment in 
patients with and without emphysema 
   The relationships between airway dimensions and FEV1 in patients with and without 
emphysema are shown in Table 4.  In patients without emphysema, FEV1 correlated 
with Ai in all bronchial generations on both inspiratory and expiratory images (the one 
exception was in the 3rd generation of B1 and B5 on expiratory images).  In addition, 
FEV1 negatively correlated with WA% in all bronchial generations on both sets of 
images. 
 
   In contrast, Ai was not correlated with FEV1 in patients with emphysema. 
Furthermore, WA% did not correlate with FEV1 in these patients except in the 4th 
generation of B8 on inspiratory images (Fig. 2). 
 
The effect of emphysema and GOLD stage on Ai changes in 5th generation bronchi  
   Respiratory Ai changes in 5th generation bronchi are shown according to GOLD 
stage and the presence or absence of emphysema (Fig. 3).  In patients with GOLD 
stage 1 or 2 disease, the change of Ai in B8 was significantly lower in patients with 
emphysema than in those without emphysema (39.6 ± 18.6 vs. 61.9 ± 16.6 %, p = 
0.001) (Fig. 3, panel B).  The change in mean Ai tended to be lower in patients with 
emphysema than in those without emphysema (32.5 ± 12.7 vs. 42.9 ± 13.6, p = 0.099) 
but this was not significant (Fig. 3, panel A).  In patients with GOLD stage 1 or 2, no 
significant difference in TLV was observed between patients with emphysema and those 
without emphysema. 
 
 
DISCUSSION 
   In the present study, airway parameters were found to be more closely associated 
with airflow limitation in patients without emphysema than in patients with emphysema. 
As previous reports[12, 14, 15], a closer relationship between airway parameters and 
airflow limitation was observed in the 5th generation airways that in the 3rd (segmental) 
or 4th (subsegmental) generation airways.  Moreover, in COPD patients with GOLD 
stages 1 and 2, the change of Ai between inspiration and expiration was lower in 
patients with emphysema than in patients without emphysema.   
   Although small airway (< 2 mm in diameter) regions in patients with COPD could 
be responsible for airflow limitations[2], direct verification of small airway structures is 
beyond the spatial resolution of clinical CT technology.  Nakano et al.[13] showed that 
Ai and WA% of the B1 segmental bronchus correlate with FEV1 and that WA%, as 
measured by HRCT, correlates with histological wall area measurements[24].  Prior 
pathology studies have shown a thickening of the large and small airways in patients 
with COPD, suggesting that CT images of the large airways could reflect the state of the 
small airways[25]. We found that emphysema affects the associations between airflow 
limitation and WA% and Ai in the 5th bronchial generation. Given the contiguous nature 
of airways from bronchus to alveoli, structural changes of the small airways, which are 
the primary determinant of airflow limitation in COPD, may be similar to those of 
larger airways.  In patients without emphysema, small airway wall structures are not 
affected by changes in alveolar structure, thus Ai and WA% in the 3rd to 5th bronchial 
generations are more closely related to FEV1.  In patients with emphysema, however, 
small airway wall structures are theoretically surrounded by emphysematous changes.  
Hence, the small airways, which are the primary determinant of airflow limitation, may 
be influenced by emphysematous changes.  It follows that, unlike patients without 
emphysema, the degree of obstructive impairment in patients with emphysema might 
not tightly correlate with changes in the 3rd to 5th bronchial generations as measured by 
MDCT.  
 
   The loss of airway tethering associated with emphysema may weaken the airway 
dilatation that normally occurs when lung volumes increase, for example during 
inspiration [17, 18, 26].  This mechanism may also weaken the relationships between 
airway dimensions and the degree of airflow impairment.  A recent study found that 
the loss of alveolar wall attachments due to emphysematous destruction leads to 
bronchiolar deformity and airway narrowing.  Scichilone et al.[17] reported that the 
bronchodilatory effect of deep inspiration was inversely correlated with the percent of 
destroyed attachments. This finding suggests that attenuation of airway stretch due to 
loss of alveolar attachments contributes to loss of the bronchodilatory effect during lung 
inflation.  Similarly, Diaz et al.[12] reported that emphysema attenuates the 
relationship between FEV1 and the WA% of subsegmental bronchi on inspiratory CT 
images. Our study demonstrated this association in peripheral airways during both 
inspiration and expiration.  
  We found that Ai of the 3rd to 5th bronchial generations was constantly smaller on 
expiratory CT images than on inspiratory images whereas WA% was larger on 
expiratory images (Table 2).  This result might be explained by the fact that airways 
stretch and contract during breathing cycles [27].  Moreover, the change in Ai in the 
right lower bronchus was smaller in COPD stage 1 and 2 patients with emphysema than 
in those patients without emphysema (Figure 3). This finding may reflect the fact that 
respiratory bronchial attitudes differ between patients with and without emphysema. 
The loss of airway tethering associated with emphysema may weaken the airway 
dilatation that normally occurs during increases in lung volume [17, 18, 26], and may 
weaken the return to functional residual capacity that normally occurs with expiration.  
Emphysema may also reduce changes in Ai by increasing local residual volume thereby 
decreasing local pulmonary ventilatory volume. We found that in COPD patients with 
GOLD stage 1 or 2 disease, changes in total lung volume did not differ between patients 
with emphysema and patients without emphysema.  Although no significant difference 
was observed in mean Ai among these patients, a significant difference was observed in 
Ai of lower bronchus.  This may be related to the fact that the lower lung parenchyma 
correlates more strongly with pulmonary function abnormalities[7]. 
The airflow limitation in COPD is caused by a combination of small airway remodeling 
and emphysema, with varying distribution and varying severity [1].  The relative 
contribution of these two pathologic processes is difficult to determine on the basis of 
standard pulmonary function tests. CT-based quantitative analyses can help differentiate 
these two processes [5, 11].  In the present study, we revealed that the correlation 
between airway disease and airflow limitation could be affected with the existence of 
emphysema.  Moreover, airway caliber changes assessed by inspiratory and expiratory 
CT enables us to understand the changes in airway on respiratory phase [15, 26].  We 
also showed that the airway caliber changes decrease in the presence of emphysema.  
Therefore, we should take into account the effects of emphysema when we focus on 
airway measurements in COPD. 
This study has several limitations. First, some patients had to be excluded from the 
study because their airway dimensions were too small for quantitative assessment.  
Second, although it has been shown that the relationship between emphysema and 
pulmonary function abnormalities varies according to the location of the 
emphysematous changes[7, 28], we did not analyze the distribution of pulmonary 
emphysema, Third, full inspiration and expiration depend upon patient effort. Patients 
were instructed to expire as much air as possible and hold at deep expiration, but  
inspiratory and expiratory efforts differed among all patients. 
 
   In conclusion, airway parameters and FEV1 were closely correlated in subjects 
without emphysema, but not in patients with emphysema.  The change of Ai during 
inspiration versus expiration was lower in patients with emphysema than in 
non-emphysematous patients.  Emphysema influenced airway dimensions, as 
measured by MDCT, even in patients with mild to moderate COPD. 
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Figures 
 
Figure 1.  Differences in airway dimensions of the 5th generation of the B8 bronchus 
in inspiratory and expiratory CT images  
   Panels A and B show inspiratory and expiratory airway dimensions in a patient with 
emphysema.  Panels C and D show inspiratory and expiratory airway dimensions in a 
patient without emphysema. Airway dimensions changed very little between inspiration 
and expiration in the patient with emphysema compared to the patient without 
emphysema. 
  
 Figure 2. The relationship between Ai and WA% of the 5th generation bronchus and 
FEV1 in patients with and without emphysema 
   Closed circles represent patients with emphysema and open circles represent 
patients without emphysema. In patients without emphysema, Ai of the 5th generation 
bronchus significantly correlated with FEV1 during both inspiratory (A) and expiratory 
(B) phases (r = 0.64: p < 0.01 and r = 0.55: p < 0.001). No correlation was observed in 
patients with emphysema. 
  In patients without emphysema, WA% of the 5th generation bronchus negatively 
correlated with FEV1 during both inspiratory (C) and expiratory (D) phases (r = -0.64: p 
< 0.001 and r = -0.58: p < 0.001). No correlation was observed in patients with 
emphysema. 
 
  
 Figure 3. The effect of GOLD stage and emphysema on Ai changes during inspiration 
and expiration.  
Compared to emphysematous patients with GOLD stage 1 or 2 COPD, 
non-emphysematous patients with GOLD stage 1 or 2 COPD tended to have larger 
changes in the mean Ai of the B1, B5 and B8 bronchi during inspiration versus 
expiration (42.9 ± 13.6 vs. 32.5 ± 12.7; p=0.099) (Panel A) and significantly greater 
changes in the Ai of the B8 bronchus (61.9 ± 16.6 vs. 39.6 ± 18.6; p=0.001) (Panel B). 
stage 1-2 non-E = non-emphysematous patients with GOLD stage 1 or 2 COPD; stage 
1-2 E = emphysematous patients with GOLD stage 1 or 2 COPD; stage 3-4 non-E = 
non-emphysematous patients with GOLD stage 3 or 4 COPD; stage 3-4 E = 
emphysematous patients with GOLD stage 3 or 4 COPD.( Mean ± SEM) 
 
Table 1. Patient characteristics. 
 
  Mean ± SD Range 
Age (years)  68.9 ± 7.9 47.0 - 84.0 
Smoking index (pack-year)  51.6 ± 29.0   8.1 - 196.0 
BMI (kg/m2)  21.8 ± 2.7 30.5 - 16.4 
FVC %pred (%)  93.7 ± 18.4  50.4 - 131.3 
FEV1 %pred (%)  66.6 ± 22.8  17.5 - 107.1 
FEV1 / FVC  56.0 ± 15.1 20.3 - 88.7 
GOLD Stage  normal / 1 / 2 / 3 / 4 (%) 14 (15.4) / 18 (19.8) / 33 (36.3) / 19 (20.9) / 7 (7.7)  
Emphysema /non-emphysema (%) 27(29.7) / 64(70.3)  
SD; standard deviation. 
Table2. The absolute values of Ai and WA% in the 3rd to 5th generations of the B1, B5 and B8 bronchi.       
 
 
 Ai (mm2)
‡
 WA (%)
‡
 
 
 inspiration expiration inspiration expiration 
B1  
   
 3rd  17.2 ± 5.7  12.9 ± 5.2  72.2 ± 4.3  76.6 ± 4.5 
 4th  8.7 ± 3.3  6.5 ± 3.1  77.0 ± 4.2  80.9 ± 4.5 
 5th  5.4 ± 2.1  3.7 ± 1.9  80.1 ± 4.4  84.5 ± 4.7 
B5  
    
 3rd  19.1 ± 6.3  16.1 ± 5.8  69.0 ± 4.7  71.6 ± 4.8 
 4th  11.5 ± 3.7  9.0 ± 3.6  72.4 ± 4.4  75.5 ± 4.4 
 5th  7.5 ± 3.1  5.3 ± 2.7  76.2 ± 5.1  80.4 ± 5.1 
B8  
    
 3rd  16.0 ± 5.3  10.9 ± 4.3  71.9 ± 4.9  76.8 ± 5.3 
 4th  8.9 ± 3.4  5.2 ± 2.6  76.0 ± 4.6  81.8 ± 5.1 
 5th  6.2 ± 2.7  2.9 ± 1.9  78.4 ± 4.7  85.8 ± 5.1 
Mean  
    
 3rd  17.4 ± 4.5  13.3 ± 3.6  71.0 ± 3.6  75.0 ± 3.5 
 4th  9.7 ± 2.7  6.9 ± 2.3  75.1 ± 3.4  79.4 ± 3.5 
 5th  6.3 ± 2.1  4.0 ± 1.7  78.2 ± 3.6  83.6 ± 3.7 
Data are mean ± standard deviation. 
‡
 p < 0.001; Wilcoxon singed-rank test. 
Table 3. The correlation between airway dimensions and the FEV1 during inspiration and expiration. 
 
  
Ai WA% 
  
inspiration expiration inspiration expiration 
B1 
     
 
3rd   0.05       0.05   - 0.20   -0.12  
 
4th   0.09    0.03   - 0.23
*
  -0.08  
 
5th   0.29
†
   0.16   - 0.35
‡
  -0.22
*
 
B5 
     
 
3rd   0.19    0.10   - 0.31
†
  -0.20  
 
4th   0.43
‡
    0.30
†
  - 0.51
‡
  -0.36
‡
 
 
5th   0.47
‡
   0.39
‡
  - 0.46
‡
  -0.37
‡
 
B8 
     
 
3rd   0.30
†
   0.17   - 0.35
‡
  -0.20  
 
4th   0.39
‡
   0.28
†
  - 0.47
‡
  -0.32
†
 
 
5th   0.39
‡
   0.20   - 0.38
‡
  -0.27
†
 
Mean 
     
 
3rd   0.20    0.07   - 0.37
‡
  -0.25
*
 
 
4th   0.35
‡
   0.22
*
  - 0.51
‡
  -0.34
†
 
 
5th   0.50
‡
   0.34
†
  - 0.53
‡
  -0.40
‡
 
 Correlation coefficients are shown (
*
 p < 0.05 ; 
†
 p < 0.01 ; 
‡ 
p < 0.001). 
Table4. The effect of the emphysema on the correlation between airway dimensions and FEV1. 
 
Ai WA % 
 
inspiratory expiratory inspiratory expiratory 
 
non- 
emphysema 
emphysema 
non- 
emphysema 
emphysema 
non- 
emphysema 
emphysema 
non- 
emphysema 
emphysema 
B1 
        
 3rd   0.32
†
  - 0.22   0.24   - 0.24  - 0.39†   0.23  - 0.38†   0.20 
 4th   0.44
‡
  - 0.21   0.43
‡
  - 0.27  - 0.54
‡
   0.05  - 0.48
‡
   0.22 
 5th   0.53
‡
  - 0.02   0.45
‡
  - 0.17  - 0.56
‡
  - 0.09  - 0.46
‡
  - 0.07 
B5 
        
 3rd   0.32
*
   0.10   0.21   0.02  - 0.44
‡
  - 0.01  - 0.30
*
  - 0.07 
 4th   0.48
‡
   0.14   0.36
†
   0.16  - 0.58
‡
  - 0.23  - 0.41
‡
  - 0.31 
 5th   0.50
‡
   0.25   0.44
‡
   0.17  - 0.48
‡
  - 0.28  - 0.42
‡
  - 0.16 
B8 
        
 3rd   0.37
†
   0.27   0.28
*
   0.18  - 0.44
‡
  - 0.23  - 0.31
*
  - 0.23 
 4th   0.45
‡
   0.34   0.43
‡
   0.24  - 0.52
‡
  - 0.42
*
  - 0.48
‡
  - 0.28 
 5th   0.48
‡
   0.15   0.36
†
   0.17  - 0.45
‡
  - 0.24  - 0.43
‡
  - 0.22 
Mean 
        
 3rd   0.45
‡
  - 0.06   0.33
†
  - 0.14  - 0.55
‡
   0.10  - 0.46
‡
  - 0.06 
 4th   0.57
‡
   0.01   0.50
‡
  - 0.03  - 0.64
‡
  - 0.27  - 0.59
‡
  - 0.13 
 5th   0.64
‡
   0.25   0.55
‡
   0.06  - 0.64
‡
  - 0.34  - 0.58
‡
  - 0.27 
Correlation coefficients are shown (
*
 p < 0.05 ; 
†
 p < 0.01 ; 
‡ 
p < 0.001) 
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